as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹698.65
Change
-2.4 (-0.34%)
Open
₹701.0
Prev. Close
₹701.05
Day High
₹711.35
Day Low
₹693.15
Volume Analysis
Traded
62,254
Delivered
31,526
Delivery %
50.64%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (4)
- •High debt-to-equity ratio (1.3)
- •Low return on equity (2.54%)
- •Promoter holding is falling
- •Below-average fundamentals quality score (46/100)
Opportunities (0)
No signal for this stock
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹727.15 | ₹719.25 | ₹708.95 | ₹701.05 | ₹690.75 | ₹682.85 | ₹672.55 |
| Fibonacci | ₹719.25 | ₹712.3 | ₹708.0 | ₹701.05 | ₹694.1 | ₹689.8 | ₹682.85 |
| Camarilla | ₹703.66 | ₹701.99 | ₹700.32 | ₹701.05 | ₹696.98 | ₹695.31 | ₹693.65 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+7.02%
1 Week
-0.38%
1 Month
+0.34%
3 Months
+11.41%
6 Months
+30.55%
1 Year
+7.92%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹42.97
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
2.41%
Net margin 1.26% × asset turnover 0.65x × equity multiplier 2.94x
Company Overview
Sector
Healthcare
Market Cap
₹10,558 Cr
P/E (TTM)
219.0
ROE
2.54%
Book Value
₹89.2
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 24 Sep 2026. Not investment advice.
TopFund Analysis
Healthcare Glob. Ent. Ltd scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 46/100. The strongest factor is Risk & Volatility (79/100), while Valuation (0/100) is the weakest area to weigh before deciding. Notably: High debt-to-equity ratio (1.3); low return on equity (2.54%). FII holding has been falling.
TopFund Score — Fundamentals Quality
46/100 — WeakData confidence: 78/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- −Stock is trading at 7.93 times its book value
- −Though the company is reporting repeated profits, it is not paying out dividend
- −Company has low interest coverage ratio.
- −Company has a low return on equity of 4.24% over last 3 years.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Intimation of Schedule of Analyst/Institutional Investor Meeting under the SEBI (LODR), Regulations 2015
Healthcare Global to meet investors/analysts on September 21, 2026, at Anand Rathi Annual Flagship Conference in Mumbai.
Nomination committee granted 64,46,843 ESOPs under HCG ESOS 2026 at Rs 495 per share.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 461 | 487 | 470 | 495 | 526 | 554 | 559 | 585 | 613 | 647 | 633 | 652 | 695 |
| Expenses + | 386 | 402 | 391 | 403 | 435 | 451 | 470 | 480 | 505 | 524 | 524 | 527 | 573 |
| Operating Profit | 74 | 85 | 79 | 92 | 91 | 102 | 88 | 106 | 108 | 123 | 110 | 125 | 122 |
| OPM % | 16.0% | 17.0% | 17.0% | 19.0% | 17.0% | 18.0% | 16.0% | 18.0% | 18.0% | 19.0% | 17.0% | 19.0% | 18.0% |
| Other Income + | 3 | 3 | 6 | 9 | 9 | 11 | 6 | 10 | 8 | 3 | -10 | -18 | 13 |
| Interest | 26 | 27 | 29 | 27 | 34 | 36 | 41 | 44 | 45 | 44 | 45 | 43 | 40 |
| Depreciation | 41 | 43 | 44 | 46 | 47 | 50 | 57 | 58 | 58 | 63 | 61 | 63 | 70 |
| Profit before tax | 11 | 18 | 11 | 28 | 19 | 28 | -3 | 14 | 12 | 20 | -6 | 1 | 25 |
| Tax % | 65.0% | 40.0% | 69.0% | 17.0% | 28.0% | 25.0% | -335.0% | 50.0% | 50.0% | -4.0% | 30.0% | -223.0% | 34.0% |
| Net Profit + | 4 | 11 | 3 | 23 | 14 | 21 | 8 | 7 | 6 | 21 | -8 | 4 | 16 |
| EPS in Rs | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | -1 | 0 | 1 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 519 | 584 | 700 | 829 | 976 | 1,092 | 1,009 | 1,395 | 1,691 | 1,908 | 2,218 | 2,538 | 2,627 |
| Expenses + | 443 | 499 | 595 | 713 | 864 | 936 | 887 | 1,161 | 1,394 | 1,581 | 1,835 | 2,080 | 2,147 |
| Operating Profit | 76 | 85 | 105 | 116 | 112 | 157 | 122 | 234 | 297 | 327 | 384 | 459 | 480 |
| OPM % | 15.0% | 15.0% | 15.0% | 14.0% | 11.0% | 14.0% | 12.0% | 17.0% | 18.0% | 17.0% | 17.0% | 18.0% | 18.0% |
| Other Income + | 0 | -2 | 10 | 25 | 10 | 10 | -72 | 110 | 15 | 24 | 39 | -11 | -13 |
| Interest | 34 | 38 | 23 | 42 | 70 | 138 | 119 | 98 | 104 | 109 | 155 | 177 | 171 |
| Depreciation | 39 | 44 | 57 | 71 | 85 | 148 | 159 | 158 | 163 | 174 | 211 | 244 | 257 |
| Profit before tax | 3 | 0 | 35 | 27 | -33 | -119 | -229 | 88 | 45 | 68 | 57 | 27 | 40 |
| Tax % | -56.0% | -730.0% | 34.0% | 38.0% | -7.0% | 5.0% | -3.0% | 56.0% | 61.0% | 39.0% | 14.0% | 15.0% | — |
| Net Profit + | 5 | 2 | 23 | 17 | -31 | -125 | -221 | 39 | 18 | 41 | 49 | 23 | 33 |
| EPS in Rs | 0 | 0 | 2 | 2 | -3 | -11 | -15 | 4 | 2 | 3 | 3 | 1 | 2 |
| Dividend Payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 210 | 341 | 347 | 428 | 389 | 293 | 572 | 731 | 721 | 686 | 783 | 1,183 |
| Borrowings + | 349 | 324 | 420 | 464 | 658 | 1,347 | 977 | 915 | 901 | 1,274 | 1,837 | 1,735 |
| Other Liabilities + | 147 | 294 | 372 | 461 | 515 | 518 | 357 | 433 | 549 | 601 | 780 | 853 |
| Total Liabilities | 776 | 1,043 | 1,225 | 1,440 | 1,650 | 2,246 | 2,031 | 2,218 | 2,311 | 2,701 | 3,540 | 3,920 |
| Fixed Assets + | 528 | 583 | 685 | 828 | 970 | 1,646 | 1,382 | 1,547 | 1,553 | 1,758 | 2,442 | 2,462 |
| CWIP | 42 | 121 | 148 | 174 | 153 | 46 | 30 | 22 | 18 | 83 | 25 | 19 |
| Investments | 0 | 64 | 11 | 53 | 49 | 34 | 26 | 9 | 10 | 10 | 11 | 14 |
| Other Assets + | 205 | 275 | 381 | 385 | 478 | 520 | 593 | 641 | 730 | 850 | 1,062 | 1,426 |
| Total Assets | 776 | 1,043 | 1,225 | 1,440 | 1,650 | 2,246 | 2,031 | 2,218 | 2,311 | 2,701 | 3,540 | 3,920 |
| Equity Capital | 70 | 85 | 86 | 87 | 88 | 89 | 125 | 139 | 139 | 139 | 139 | 149 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 60 | 73 | 91 | 98 | 98 | 130 | 121 | 220 | 252 | 285 | 317 | 347 |
| Cash from Investing Activity + | -79 | -204 | -210 | -283 | -238 | -101 | -171 | 125 | -133 | -226 | -488 | -177 |
| Cash from Financing Activity + | 22 | 216 | 89 | 161 | 84 | -58 | 112 | -155 | -140 | -64 | -42 | 241 |
| Net Cash Flow | 2 | 85 | -29 | -24 | -56 | -30 | 62 | 190 | -22 | -5 | -213 | 410 |
| CFO/OP | 87 | 99 | 93 | 88 | 121 | 100 | 68 | 104 | 92 | 101 | 91 | 83 |
| Free Cash Flow | -20 | -137 | -101 | -158 | -90 | 23 | 85 | 150 | 126 | 101 | 110 | 59 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 14.49% | 13.89% | 13.45% | 13.9% | 12.84% | 13.07% | 13.86% | 22.17% | 14.28% | 14.71% | 14.15% | 13.86% |
| Promoters | 71.3% | 71.29% | 71.28% | 71.26% | 71.23% | 71.22% | 71.22% | 62.46% | 63.78% | 63.77% | 64.21% | 64.21% |
| FII | 6.29% | 6.37% | 6.74% | 3.95% | 4.3% | 2.77% | 2.44% | 2.16% | 3.59% | 3.22% | 2.76% | 2.73% |
| DII | 7.94% | 8.46% | 8.52% | 10.89% | 11.64% | 12.94% | 12.48% | 13.22% | 18.36% | 18.3% | 18.91% | 19.2% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Healthcare Glob. Ent. Ltd (this stock) | 10,558 | 219.0 | 7.93 | 2.54% |
| Viyash Scientific Limited | 10,791 | 48.7 | 3.66 | 7.39% |
| Yatharth Hosp & Tra C S L | 10,899 | 60.2 | 6.1 | 10.4% |
| Strides Pharma Sci Ltd | 10,922 | 18.8 | 3.52 | 20.0% |
| Blue Jet Healthcare Ltd | 11,040 | 78.3 | — | 52.1% |
| Suven Life Sciences Ltd | 9,466 | — | 14.96 | -81.5% |
| Metropolis Healthcare Ltd | 12,086 | 58.1 | 7.99 | 13.6% |
Which Mutual Funds Hold Healthcare Glob. Ent. Ltd?
Frequently Asked Questions about Healthcare Glob. Ent. Ltd
Healthcare Glob. Ent. Ltd (HCG) closed at ₹698.65 on NSE on 25 September 2026, down 2.4 (0.34%) from the previous close.
Healthcare Glob. Ent. Ltd trades on the NSE (National Stock Exchange of India) under the symbol HCG.
Healthcare Glob. Ent. Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 219.0.
Healthcare Glob. Ent. Ltd has a dividend yield of 0.0%.
Healthcare Glob. Ent. Ltd's 52-week high is ₹800.0 and its 52-week low is ₹513.0.
Healthcare Glob. Ent. Ltd has a market capitalisation of ₹10,558 crore.
Healthcare Glob. Ent. Ltd has a TopFund Quality Score of 46/100 (Weak), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Healthcare Glob. Ent. Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.